Many drugs that older patients are given are potentially inappropriate, ie, their risks outweigh the expected benefi ts, particularly when effective and safer alternative therapies exist. Although many clinicians are aware of the risks of polypharmacy, they may not be confi dent in discontinuing potentially inappropriate medications. The process of deliberately tapering, stopping, or reducing doses of medications with the goal of reducing harm and improving patient outcomes is known as deprescribing. 3 In this issue, Kim et al 4 review several medications that are overused or often used inappropriately in older adults: statins for primary prevention of atherosclerotic cardiovascular disease, anticholinergic drugs, benzodiazepines, antipsychotics, and proton pump inhibitors. They offer guidance about the situations in which these drugs may be inappropriate as well as alternative drug and nondrug treatments. Further, they suggest that, when prescribing or deprescribing drugs in older adults, clinicians consult tools such as the Beers criteria and the STOPP/START criteria (the Screening Tool of Older Persons' Potentially Inappropriate Prescriptions, and the Screening Tool to Alert Doctors to Right Treatment).
The issues Kim et al review are highly relevant and may increase awareness of specifi c potentially inappropriate medications. They also remind us that nonpharmacologic treatments are fi rst-line for many medical conditions. In an era of a pill for every ill and a quick-fi x mentality among both patients and providers, lifestyle changes and other nonpharmacologic treatments may be overlooked. Similarly, the STOPP/START criteria, which are concrete, evidence-based recommendations that can be applied to patient care, are likely underused in clinical practice.
Although necessary and valuable, simply arming clinicians with knowledge is insufficient to tackle the problems of polypharmacy and inappropriate prescribing. As the authors note in their discussion of benzodiazepines, practice guidelines exist regarding prescribing these agents, and data from randomized trials support specifi c interventions to deprescribe them. 5 Nevertheless, clinicians report feeling inadequately prepared to discontinue benzodiazepines, particularly when patients perceive benefi t from them. As such, user-friendly tools and specifi c strategies for weighing risks vs benefi ts are critical for clinicians. An opportunity arises when patients are in the hospital. Taking a medication history on admission and matching medications with indications are key starting points. Clinical pharmacists can help screen for side effects and potential interactions and can provide deprescribing recommendations. Meticulous discharge medication reconciliation, patient education, and communication of the updated medication list to the outpatient provider are central to ensuring that patients adhere to medication adjustments after they go home.
■ PUTTING KNOWLEDGE INTO PRACTICE

■ A MATTER OF BALANCE
Another factor to consider is the patient's physiologic age compared with his or her chronologic age. If a patient has multiple comorbidities, frailty, limited life expectancy, or poor renal function, we may consider her older than her chronologic age. In this case, a drug's risks may outweigh its benefi t, which is something to be discussed. On the other hand, a high-functioning and relatively healthy elderly patient may be a candidate for medications known to reduce the risk of death or control a chronic disease better. Incorporating a patient's goals of care and using shared decision-making are also likely to yield an optimal medication regimen.
Smartphone apps and resources embedded in electronic health records provide additional decision support. Used when prescribing or reconciling medications, these supplemental brains offer instant feedback and information on dose adjustments, drug interactions, clinical guidelines, and even potentially inappropriate medications. While the impacts of these electronic tools on prescribing patterns and outcomes in geriatric populations remain unclear, new ones are being developed and studied. 6 This may be the most promising way to translate knowledge into practice, as it is more easily integrated with existing clinician workfl ows.
■ AN OPPORTUNITY TO IMPROVE
There is signifi cant opportunity to reduce polypharmacy and optimize medication prescribing practices for older adults. Awareness of potentially inappropriate medications and clinical situations in which the use of certain classes of medications should be minimized is the fi rst step in addressing this problem. Using tools such as the STOPP/START criteria, reviewing medications at critical transition points, prioritizing patient function and goals, and using electronic clinical decision support should aid prescribing decisions.
Whenever possible, collaborating with other care team members such as pharmacists may increase effi ciency and effectiveness of medication management. Ultimately, inclusion of more older adults in clinical trials may provide data-driven guidance for weighing risks and benefi ts. Finally, further study of the effects of deprescribing on clinical outcomes may be the missing piece to help clinicians and patients fi nd balance in prescription management. ■
